These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 12745358)

  • 1. Enough! or too much. What is 'excessive' kava use in Arnhem Land?
    Clough A
    Drug Alcohol Rev; 2003 Mar; 22(1):43-51. PubMed ID: 12745358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diversity of substance use in eastern Arnhem Land (Australia): patterns and recent changes.
    Clough AR; Guyula T; Yunupingu M; Burns CB
    Drug Alcohol Rev; 2002 Dec; 21(4):349-56. PubMed ID: 12537704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kava use, dyslipidaemia and biomarkers of dietary quality in Aboriginal people in Arnhem Land in the Northern Territory (NT), Australia.
    Clough AR; Rowley K; O'Dea K
    Eur J Clin Nutr; 2004 Jul; 58(7):1090-3. PubMed ID: 15220953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging patterns of cannabis and other substance use in Aboriginal communities in Arnhem Land, Northern Territory: a study of two communities.
    Clough AR; D'Abbs P; Cairney S; Gray D; Maruff P; Parker R; O'Reilly B
    Drug Alcohol Rev; 2004 Dec; 23(4):381-90. PubMed ID: 15763742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Policy approaches to support local community control over the supply and distribution of kava in the Northern Territory (Australia).
    Clough AR; Jones PJ
    Drug Alcohol Rev; 2004 Mar; 23(1):117-26. PubMed ID: 14965893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health effects of kava use in an eastern Arnhem Land Aboriginal community.
    Clough AR; Jacups SP; Wang Z; Burns CB; Bailie RS; Cairney SJ; Collie A; Guyula T; McDonald SP; Currie BJ
    Intern Med J; 2003 Aug; 33(8):336-40. PubMed ID: 12895162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver function test abnormalities in users of aqueous kava extracts.
    Clough AR; Bailie RS; Currie B
    J Toxicol Clin Toxicol; 2003; 41(6):821-9. PubMed ID: 14677792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a community-driven preventive youth initiative in Arnhem Land, Northern Territory, Australia.
    Lee KS; Conigrave KM; Clough AR; Wallace C; Silins E; Rawles J
    Drug Alcohol Rev; 2008 Jan; 27(1):75-82. PubMed ID: 18034384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dental self-care and dietary characteristics of remote-living Indigenous children.
    Jamieson LM; Bailie RS; Beneforti M; Koster CR; Spencer AJ
    Rural Remote Health; 2006; 6(2):503. PubMed ID: 16646637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validity and utility of community health workers' estimation of kava use.
    Clough AR; Baille R; Burns CB; Guyula T; Wunungmurra R; Wanybarrnga SR
    Aust N Z J Public Health; 2002 Feb; 26(1):52-7. PubMed ID: 11895027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case-control study of the association between kava use and pneumonia in eastern Arnhem and Aboriginal communities (Northern Territory, Australia).
    Clough AR; Wang Z; Bailie RS; Burns CB; Currie BJ
    Epidemiol Infect; 2003 Aug; 131(1):627-35. PubMed ID: 12948361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kava consumption and its health effects.
    Gounder R
    Pac Health Dialog; 2006 Sep; 13(2):131-5. PubMed ID: 18181402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case-control study of the association between kava use and ischaemic heart disease in Aboriginal communities in eastern Arnhem Land (Northern Territory) Australia.
    Clough AR; Wang Z; Bailie RS; Burns CB; Currie BJ
    J Epidemiol Community Health; 2004 Feb; 58(2):140-1. PubMed ID: 14729896
    [No Abstract]   [Full Text] [Related]  

  • 14. The adverse effects of kava.
    Kava R
    Pac Health Dialog; 2001 Mar; 8(1):115-8. PubMed ID: 12017812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential association of C-reactive protein with adiposity in men and women in an Aboriginal community in northeast Arnhem Land of Australia.
    Shemesh T; Rowley KG; Jenkins A; Brimblecombe J; Best JD; O'Dea K
    Int J Obes (Lond); 2007 Jan; 31(1):103-8. PubMed ID: 16682979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Saccade and cognitive impairment associated with kava intoxication.
    Cairney S; Maruff P; Clough AR; Collie A; Currie J; Currie BJ
    Hum Psychopharmacol; 2003 Oct; 18(7):525-33. PubMed ID: 14533134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in cannabis use and its consequences over 3 years in a remote indigenous population in northern Australia.
    Clough AR; Lee KS; Cairney S; Maruff P; O'Reilly B; d'Abbs P; Conigrave KM
    Addiction; 2006 May; 101(5):696-705. PubMed ID: 16669903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-year longitudinal study of cannabis users in three remote Aboriginal communities in Arnhem Land, Northern Territory, Australia.
    Lee KS; Conigrave KM; Clough AR; Dobbins TA; Jaragba MJ; Patton GC
    Drug Alcohol Rev; 2009 Nov; 28(6):623-30. PubMed ID: 19930015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between tobacco and cannabis use in remote indigenous populations in Northern Australia.
    Clough AR
    Addiction; 2005 Mar; 100(3):346-53. PubMed ID: 15733248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Traditional kava beverage consumption and liver function tests in a predominantly Tongan population in Hawaii.
    Brown AC; Onopa J; Holck P; Kaufusi P; Kabasawa D; Craig WJ; Dragull K; Levine AM; Baker JD
    Clin Toxicol (Phila); 2007; 45(5):549-56. PubMed ID: 17503265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.